Events

Events

These events and webinars are intended for veterinary professionals only.

Event
Date and location

Leveraging Procedural Sedation for Canine Patients #24134

Speaker:
James Sturzione, DVM, MBS

Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.

7:00 PM EDT

1 RACE-Approved Credit  

Tuesday, April 16, 2024, 19:00 - 20:00
location_on Dinner Meeting, Springfield, MA

Register now

Zennovation in Sedation: Rethinking What is Possible #24179

Speaker:
Julie Kluxdal, DVM

In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.

7:00 PM PDT

1 RACE-Approved Credit  

RACE# 27059-918761

Tuesday, April 16, 2024, 19:00 - 20:00
location_on Dinner Meeting, Reno, NV

Register now

Zennovation in Sedation: Rethinking What is Possible #24194

Speaker:
Gregory Long, DVM

In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.

7:00 PM EDT

1 RACE-Approved Credit  

RACE# 27059-918761

Tuesday, April 16, 2024, 19:00 - 20:00
location_on Dinner Meeting, Marathon, FL

Register now

Equine Osteoarthritis and Chondroprotective Therapies #24016

Speaker:
Greg Schmid, DVM

The presenter reviews equine osteoarthritis (OA) and chondroprotective therapies. Focus areas include basic anatomy of the joint, articular cartilage composition and function, pathophysiology of OA including histologic progression, and types of chondroprotective therapies. The types of therapies discussed will include Hyaluronate Sodium (HA), Glycosaminoglycan (PSGAG), Pentosan Polysulfate (PPS) and regenerative autologous blood products currently indicated for OA and/or degenerative joint disease in horses. Additionally a meta-analysis of current research with regard to equine OA treatments will be analyzed.

07:00 PM EST

RACE# 27059-1077078

1 RACE-Approved Credit Hour 
 

Wednesday, April 17, 2024, 19:00 - 20:00
location_on Virtual Meeting

Register now

Leveraging Procedural Sedation for Canine Patients #24152

Speaker:
Jim Lowe, DVM

Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.

7:00 PM EDT

1 RACE-Approved Credit  

Wednesday, April 17, 2024, 19:00 - 20:00
location_on Dinner Meeting, Indianapolis, WA

Register now

Leveraging Procedural Sedation for Canine Patients #24168

Speaker:
Jennifer Kasten, DVM

Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.

7:00 PM EDT

1 RACE-Approved Credit  

Wednesday, April 17, 2024, 19:00 - 20:00
location_on Dinner Meeting, Cincinnati, OH

Register now

Verdinexor: A Novel Oral Therapy for Canine Lymphoma #24153

Speaker:
Jim Lowe, DVM

This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.

7:00 PM EDT

1 RACE-Approved Credit  

RACE# 27059-900255 

Thursday, April 18, 2024, 19:00 - 20:00
location_on Dinner Meeting, New Castle, IN

Register now

Leveraging Procedural Sedation for Canine Patients #24148

Speaker:
Jennifer Kasten, DVM

Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.

7:00 PM EDT

1 RACE-Approved Credit  

Leveraging Procedural Sedation for Canine Patients #24149

Speaker:
Jennifer Kasten, DVM

Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.

7:00 PM EDT

1 RACE-Approved Credit  

Wednesday, April 24, 2024, 19:00 - 20:00
location_on Dinner Meeting, Latham, NY

Register now

Zennovation in Sedation: Rethinking What is Possible #24214

Speaker:
Gregory Long, DVM

In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.

7:00 PM EDT

1 RACE-Approved Credit  

RACE# 27059-918761

Wednesday, April 24, 2024, 19:00 - 20:00
location_on Dinner Meeting, Tampa, FL

Register now

Verdinexor: A Novel Oral Therapy for Canine Lymphoma #24131

Speaker:
Katie Marcus, DVM

This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.

7:00 PM MDT

1 RACE-Approved Credit  

RACE# 27059-900255 

Thursday, April 25, 2024, 19:00 - 20:00
location_on Dinner Meeting, Idaho Falls, ID

Register now

Verdinexor: A Novel Oral Therapy for Canine Lymphoma #24017

Speaker:
Katie Marcus, DVM

This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.

10:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-900255 

Thursday, April 25, 2024, 22:00 - 23:00
location_on Virtual Meeting

Register now

Ears to Rears and everything in between... Why Otic and Skin Cytology is so Important #24018

Speaker:
Cynthia Bauer, DVM, MS, Dipl. ACVD

This presentation will be a case-based discussion on the importance of skin and otic cytology. The presenter will talk about how to diagnose and manage infections using topical therapy and why having cytology is important to improve positive outcomes.

6:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-1119680

Tuesday, April 30, 2024, 18:00 - 19:00
location_on Virtual Meeting

Register now

Verdinexor: A Novel Oral Therapy for Canine Lymphoma #24196

Speaker:
James Sturzione, DVM, MBS

This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.

7:00 PM EDT

1 RACE-Approved Credit  

RACE# 27059-900255 

Tuesday, April 30, 2024, 19:00 - 20:00
location_on Dinner Meeting, Hartford, CT

Register now

Verdinexor: A Novel Oral Therapy for Canine Lymphoma #24206

Speaker:
Julie Kluxdal, DVM

This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.

7:30 PM PDT

1 RACE-Approved Credit  

RACE# 27059-900255 

Wednesday, May 1, 2024, 19:30 - 20:30
location_on Dinner Meeting, San Diego, CA

Register now

Zennovation in Sedation: Rethinking What is Possible #24207

Speaker:
Julie Kluxdal, DVM

In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.

7:30 PM PDT

1 RACE-Approved Credit  

RACE# 27059-918761

Thursday, May 2, 2024, 19:30 - 20:30
location_on Dinner Meeting, San Diego, CA

Register now

Todays PSA: Procedural Sedation and Analgesia for the Vet Tech #24019

Speaker:
Katrina Lafferty, BFA, RLAT, CVT, VTS (Anesthesia/Analgesia)

The reasons to sedate our veterinary patients are many. Sedation allows for less stressful handling, positioning, and diagnostic collection for both the patient and veterinary staff. Radiographs, biopsies, IV catheter placement, and potentially even physical exam, nail trimming, ear cleaning and other maintenance procedures can be achieved with more accuracy and safety, and believe it or not, more quickly with appropriate sedation. No one drug possesses every desired quality (reliable sedation, good analgesia, reversibility, minimal side effects) so it is necessary to have a good understanding of many options and combinations so you can choose the right fit for the right situation. A sedation protocol should consider patient personality, comorbities, procedure, and preferred recovery time. The specific drugs and amounts used will depend on several factors. The anesthetist creating the plan will have to evaluate the temperament of the patient, the type of procedure being performed, and the coexisting conditions or contraindications each patient may have.

8:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-1119946

Thursday, May 2, 2024, 20:00 - 21:00
location_on Virtual Meeting

Register now

Zennovation in Sedation: Rethinking What is Possible #24150

Speaker:
Elizabeth Mongol-Gunter, VMD

In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.

7:00 PM EDT

1 RACE-Approved Credit  

RACE# 27059-918761

Tuesday, May 7, 2024, 19:00 - 20:00
location_on Dinner Meeting, Clifton, VA

Register now

Update on Managing Canine Hyperadrenocorticism #24216

Speaker:
Sam Gindville, DVM

Canine Hyperadrenocorticism (Cushing’s Disease) can be a challenging yet rewarding disease to manage. This presentation will review all aspects of Cushing’s: basic pathophysiology, clinical signs, diagnostics, differentiating tests, treatment and monitoring. A series of cases to increase understanding of managing Cushing’s patients will be presented and the final section highlights ways to enhance owner compliance.

07:00 PM CDT

RACE# 27059-869593

1.5 RACE-Approved Credit Hour 
 

Tuesday, May 7, 2024, 19:00 - 20:00
location_on Dinner Meeting, Austin, TX

Register now

Zennovation in Sedation: Rethinking What is Possible #24229

Speaker:
Kathy Engler, DVM, DABVP

In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.

7:00 PM CDT

1 RACE-Approved Credit  

RACE# 27059-918761

Tuesday, May 7, 2024, 19:00 - 20:00
location_on Dinner Meeting, Ankeny, IA

Register now

Zennovation in Sedation: Rethinking What is Possible #24188

Speaker:
Elizabeth Mongol-Gunter, VMD

In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.

7:00 PM EDT

1 RACE-Approved Credit  

RACE# 27059-918761

Wednesday, May 8, 2024, 19:00 - 20:00
location_on Dinner Meeting, Arlington, VA

Register now

Maximizing Topical Therapy in Companion Animal Practice #24217

Speaker:
Sam Gindville, DVM

With dermatologic conditions making up a large volume of the caseload in companion animal medicine and with antimicrobial resistance on the rise, topical therapies need to play a bigger role in dermatologic therapy. This presentation will discuss why topical therapies are helpful and how cytology helps guide topical product choice. The most common active ingredients in topical products for companion animals will be highlighted including their mechanism of action and suggested use. By having a complete understanding of active ingredients, veterinarians will be better equipped to make a topical product selection. Compliance strategies will be discussed to help ensure that what a veterinarian prescribes actually gets used.With dermatologic conditions making up a large volume of the caseload in companion animal medicine and with antimicrobial resistance on the rise, topical therapies need to play a bigger role in dermatologic therapy. This presentation will discuss why topical therapies are helpful and how cytology helps guide topical product choice. The most common active ingredients in topical products for companion animals will be highlighted including their mechanism of action and suggested use. By having a complete understanding of active ingredients, veterinarians will be better equipped to make a topical product selection. Compliance strategies will be discussed to help ensure that what a veterinarian prescribes actually gets used.

07:00 PM CDT

1 RACE-Approved Credit Hour 
 

Wednesday, May 8, 2024, 19:00 - 20:00
location_on Dinner Meeting, Georgetown, TX

Register now

Verdinexor: A Novel Oral Therapy for Canine Lymphoma #24230

Speaker:
Kathy Engler, DVM, DABVP

This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.

7 PM CDT

1 RACE-Approved Credit  

RACE# 27059-900255 

Wednesday, May 8, 2024, 19:00 - 20:00
location_on Dinner Meeting, Ankeny, IA

Register now

Successful Sedation Protocols in Everyday Practice #24020

Speaker:
Zenithson Ng, DVM, DABVP

This program will review commonly used sedation protocols and applications in general practice. The speaker will discuss reducing Fear, Anxiety and Stress in the patients and the veterinary team. He will review common methods of pre visit pharmaceuticals, in hospital sedation and examples of protocols that he has successfully used in practice. Finally he will use real-life case examples of sedation and improving FAS for everyone involved.

8:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-111944

Wednesday, May 8, 2024, 20:00 - 21:00
location_on Virtual Meeting

Register now

Leveraging Procedural Sedation for Canine Patient #24226

Speaker:
Katie Marcus, DVM

Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.

7:00 PM MDT

1 RACE-Approved Credit  

Thursday, May 9, 2024, 19:00 - 20:00
location_on Dinner Meeting, Lone Tree, CO

Register now

If You're Not Seeing Canine Lymphoma Cases, They Might Be Seeing You! #24021

Speaker:
Natalie Marks, DVM, CVJ

This presentation will start with a quick review of the prevalence of canine lymphoma and why early diagnosis is critical. The bulk of the lecture will focus on five critical areas the veterinary team can focus on for earlier diagnostics and education to pet parents. This includes at-risk breeds, questions to ask in the history, commonly missed clinical signs, subtle physical exam findings that dictate further diagnostics, and recommended workup options (including the spectrum of care.) The final sections of this presentation will discuss how to utilize resources for efficient and effective communication in your practice.

7:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-1174212 

Thursday, May 16, 2024, 19:00 - 20:00
location_on Virtual Meeting

Register now

Leveraging Procedural Sedation for Canine Patient #24125

Speaker:
Jennifer Kasten, DVM

Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.

7:00 PM EDT

1 RACE-Approved Credit  

Tuesday, May 21, 2024, 19:00 - 20:00
location_on Dinner Meeting, Bath, OH

Register now

PU, PD, Polyphagia - Oh My! Canine Hypercortisolism #24022

Speaker:
Andrew Bugbee, DVM, DACVIM SAIM

This program will walk through the clinical signs, diagnosis, and treatment of Hypercortisolism (Cushing's). The speaker will use a case-based approach to discuss new monitoring protocols and treatment possibilities.

8:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-1122012 

Tuesday, May 21, 2024, 22:00 - 23:00
location_on Virtual Meeting

Register now

Verdinexor: A Novel Oral Therapy for Canine Lymphoma #24126

Speaker:
Jennifer Kasten, DVM

This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.

7:00 PM EDT

1 RACE-Approved Credit  

RACE# 27059-900255 

Wednesday, May 22, 2024, 19:00 - 20:00
location_on Dinner Meeting, Twinsburg, OH

Register now

Canine Regenerative Therapy- Autologous Blood Products #24075

Speaker:
Timothy Smaha, DVM

The presenter reviews canine regenerative therapy. Focus areas include basic principles of regenerative medicine, FDA regulations, and types of autologous blood products. The types of medical devices necessary for processing autologous blood products including centrifugation, filtration, and incubation are all discussed. Additionally a review of current literature on validation of different autologous products in canines and felines will be discussed. Finally there will be a review of the current literature on the uses of Platelet rich plasma in small animal medicine and an overview of how to perform joint injections for companion animals.

8:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-973692

Thursday, May 23, 2024, 20:00 - 21:00
location_on Virtual Meeting

Register now

Equine Regenerative Therapy - Autologous Blood Products #24023

Speaker:
Lea Walker, DVM, DACVSMR

The presenter reviews equine regenerative therapy. Focus areas include basic principles of regenerative medicine, FDA regulations, and types of autologous blood products. The types of medical devices necessary for processing autologous blood products including centrifugation, filtration, and incubation are all discussed. Additionally, a meta-analysis of current research with regard to platelet rich plasma (PRP), autologous conditioned serum (ACS), autologous protein solutions (APS), and alpha 2 macroglobulin will be analyzed.

7:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-924918

Wednesday, May 29, 2024, 19:00 - 20:00
location_on Virtual Meeting

Register now

Canine Regenerative Therapy- Autologous Blood Products #24076

Speaker:
Timothy Smaha, DVM

The presenter reviews canine regenerative therapy. Focus areas include basic principles of regenerative medicine, FDA regulations, and types of autologous blood products. The types of medical devices necessary for processing autologous blood products including centrifugation, filtration, and incubation are all discussed. Additionally a review of current literature on validation of different autologous products in canines and felines will be discussed. Finally there will be a review of the current literature on the uses of Platelet rich plasma in small animal medicine and an overview of how to perform joint injections for companion animals.

3:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-973692

Monday, June 3, 2024, 15:00 - 16:00
location_on Virtual Meeting

Register now

Canine Regenerative Therapy- Autologous Blood Products #24077

Speaker:
Katie Marcus, DVM

The presenter reviews canine regenerative therapy. Focus areas include basic principles of regenerative medicine, FDA regulations, and types of autologous blood products. The types of medical devices necessary for processing autologous blood products including centrifugation, filtration, and incubation are all discussed. Additionally a review of current literature on validation of different autologous products in canines and felines will be discussed. Finally there will be a review of the current literature on the uses of Platelet rich plasma in small animal medicine and an overview of how to perform joint injections for companion animals.

10:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-973692

Wednesday, June 5, 2024, 22:00 - 23:00
location_on Virtual Meeting

Register now

Navicular Syndrome and Clinical Application of Bisphosphonates in Equine Practice #24024

Speaker:
Brett Turi, DVM

This presentation breaks down the complex mechanisms of bisphosphonates as a drug class and their use in managing the clinical signs of navicular syndrome in horses. The second half of the presentation explores the clinical features of non-nitrogenous bisphosphonates including their efficacy and safety in real world field applications.

7:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-963582

Thursday, June 6, 2024, 19:00 - 20:00
location_on Virtual Meeting

Register now

Zennovation in Sedation: Rethinking What is Possible #24025

Speaker:
Kathy Engler, DVM, DABVP

In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.

12:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-918761

Tuesday, June 11, 2024, 12:00 - 13:00
location_on Virtual Meeting

Register now

Verdinexor: A Novel Oral Therapy for Canine Lymphoma #24026

Speaker:
Gregory Long, DVM

This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.

7:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-900255 

Wednesday, June 19, 2024, 19:00 - 20:00
location_on Virtual Meeting

Register now

Addison’s Disease Cases and Treatment Review #24027

Speaker:
Cynthia Ward, VMD, PhD, DACVIM SAIM

This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.

7:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-900255 

Thursday, June 27, 2024, 19:00 - 20:00
location_on Virtual Meeting

Register now

keyboard_arrow_up